Halozyme Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Aug 23 | SellUS$874,520 | James Daly | Individual | 20,000 | US$43.74 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 22,741 | 0.0178% |
State or Government | 48,164 | 0.0376% |
Individual Insiders | 1,330,896 | 1.04% |
Institutions | 126,645,036 | 98.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
18,630,963 | US$709.8m | 2.83% | 0.01% | |||
13,259,514 | US$505.2m | 1.17% | 0.01% | |||
6,689,058 | US$254.9m | -13.3% | 0.21% | |||
6,475,549 | US$246.7m | 4.28% | 0.01% | |||
3,709,599 | US$141.3m | -14.2% | 3.21% | |||
3,463,694 | US$132.0m | 3.19% | 0.04% | |||
3,282,640 | US$125.1m | -4.69% | 0.14% | |||
2,919,763 | US$111.2m | 4.75% | 0.01% | |||
2,730,408 | US$104.0m | -8.81% | 0.01% | |||
2,226,538 | US$84.8m | -5.02% | 0.77% | |||
1,983,916 | US$75.6m | 517% | 0.06% | |||
1,973,744 | US$75.2m | -1.71% | 0.01% | |||
1,921,659 | US$73.2m | -4.6% | 0.14% | |||
1,812,344 | US$69.1m | 3.24% | 0.02% | |||
1,736,122 | US$66.1m | 0% | 0.01% | |||
1,613,113 | US$61.5m | 9.94% | 0.01% | |||
1,576,083 | US$60.0m | 3.17% | 0.69% | |||
1,518,455 | US$57.9m | 4.38% | 0.82% | |||
1,389,837 | US$53.0m | -11.4% | 0.01% | |||
1,387,613 | US$52.9m | -1.66% | 0.01% | |||
1,215,769 | US$46.3m | 28.2% | no data | |||
1,203,716 | US$45.9m | -6.2% | 0.01% | |||
1,163,033 | US$44.3m | 250% | 0.06% | |||
1,015,998 | US$38.7m | -24.5% | 0.01% | |||
949,324 | US$36.2m | -2.13% | 0.05% |